DH
Danaher
DHR · NYSE
$204.99 -0.12% (-$0.24)
1M -1.25%
Market Cap $144.1B
P/E Ratio 35.99x
Div. Yield 0.70%
ROE 7.66%
Bulios Fair Price
$128.92
37.1% downside
Trenutna cena
$204.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DHR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
31 /100
Expensive P/E 35.99x
EV/EBITDA 23.26x
P/S 5.74x
Growth
6 /100
Declining EPS growth 19.44%
Rev. growth 2.67%
FCF growth 10.62%
Profitability
93 /100
Strong Gross margin 58.51%
Net margin 15.95%
Op. margin 20.42%
Quality
30 /100
Poor ROIC 5.03%
ROE 7.66%
ROA 4.33%
Debt
71 /100
Low Debt/Equity 0.51x
Current ratio 1.65x
Int. coverage 64.79x
Stability
100 /100
Stable Beta 0.80x
Rev. volatility 6.95%
EPS volatility 14.60%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DHR
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair
Employees
59,000
Headquarters
Washington
Prihajajoči dogodki
20 OKT.
Earnings
Upcoming earnings report